New York State’s Wadsworth Lab And NYC’s Public-Health Lab Win Go-Ahead For COVID-19 Testing

The US FDA on 29 February approved New York State’s and New York City’s combined Emergency Use Authorization request to conduct coronavirus testing at the state’s Wadsworth Center laboratory in Albany, and its NYC public-health department-based lab. Both sites are CLIA-certified to proceed using COVID-19 laboratory-developed tests, the FDA’s Tim Stenzel said during a 2 March webinar on virus testing.

New York, NY - February 2, 2020: Governor Andrew Cuomo with Dr. Howard Zucker & Rick Cotton updated press on status of testing for novel coronavirus in New York State at 633 Third Avenue
New York Gov. Andrew Cuomo (center) with N.Y. public health officials Howard Zucker (left) and Rick Cotton (right), give an update on testing for COVID-19 in the state during a February press conference • Source: Shutterstock

The US Food and Drug Administration has issued an Emergency Use Authorization (EUA) to two New York-based CLIA-certified laboratories, permitting them to use their molecular-based diagnostic for patients suspected of carrying coronavirus.

So said Tim Stenzel, director of the FDA’s Office of In Vitro Diagnostics and Radiological Health (OIR), during a 2...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Regulation

More from Policy & Regulation